Indapamide is superior to thiazide in the preservation of renal function in patients with renal insufficiency and systemic hypertension

Am J Cardiol. 1996 Feb 22;77(6):23B-25B. doi: 10.1016/s0002-9149(97)89236-3.

Abstract

The long-term effects of indapamide or hydrochlorothiazide on blood presssure and renal function were examined in patents with impaired renal function and moderate hypertension. Both drugs controlled hypertension and blood pressure remained normal during the 2 years of the study. Despite this comparable control of hypertension, indapamide therapy was associated with a 28.5 +/- 4.4% increase in creatinine clearance, whereas treatment with hydrochlorothiazide was associated with a 17.4 +/- 3.0% decrease in creatinine clearance. The results of the study indicate that indapamide is superior to hydrochlorothiazide in the treatment of patients with impaired renal function and moderate hypertension.

Publication types

  • Clinical Trial
  • Comparative Study
  • Multicenter Study
  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Aged
  • Antihypertensive Agents / therapeutic use*
  • Diuretics / therapeutic use*
  • Female
  • Humans
  • Hydrochlorothiazide / therapeutic use*
  • Hypertension / complications
  • Hypertension / drug therapy*
  • Indapamide / therapeutic use*
  • Kidney Function Tests
  • Male
  • Middle Aged
  • Renal Insufficiency / complications
  • Renal Insufficiency / physiopathology*
  • Sodium Chloride Symporter Inhibitors / therapeutic use*
  • Time Factors

Substances

  • Antihypertensive Agents
  • Diuretics
  • Sodium Chloride Symporter Inhibitors
  • Hydrochlorothiazide
  • Indapamide